SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 214 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $82,000 | -46.1% | 92,656 | -4.0% | 0.00% | – |
Q3 2022 | $152,000 | -22.1% | 96,507 | -0.5% | 0.00% | – |
Q2 2022 | $195,000 | +10.8% | 96,988 | +28.3% | 0.00% | – |
Q1 2022 | $176,000 | -52.7% | 75,591 | -5.5% | 0.00% | – |
Q4 2021 | $372,000 | -48.0% | 80,001 | -14.7% | 0.00% | – |
Q3 2021 | $716,000 | -18.7% | 93,824 | +0.4% | 0.00% | – |
Q2 2021 | $881,000 | +30.7% | 93,461 | +14.6% | 0.00% | – |
Q1 2021 | $674,000 | +37.8% | 81,566 | +13.8% | 0.00% | – |
Q4 2020 | $489,000 | -45.2% | 71,681 | -10.5% | 0.00% | – |
Q3 2020 | $893,000 | +120.0% | 80,081 | +23.8% | 0.00% | – |
Q2 2020 | $406,000 | +241.2% | 64,681 | +0.0% | 0.00% | – |
Q1 2020 | $119,000 | +250.0% | 64,676 | +414.1% | 0.00% | – |
Q2 2019 | $34,000 | -43.3% | 12,580 | -0.7% | 0.00% | – |
Q1 2019 | $60,000 | +93.5% | 12,670 | -2.4% | 0.00% | – |
Q4 2018 | $31,000 | -63.5% | 12,980 | -32.9% | 0.00% | – |
Q3 2018 | $85,000 | -39.7% | 19,330 | -1.0% | 0.00% | – |
Q2 2018 | $141,000 | -92.2% | 19,530 | -80.9% | 0.00% | -100.0% |
Q2 2015 | $1,802,000 | – | 102,301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
EMFO, LLC | 209,398 | $185,527 | 0.19% |
Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
Mayo Clinic | 300,000 | $267,000 | 0.14% |
swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |